Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
Open Access
- 19 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Imaging
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s40644-021-00392-9
Abstract
Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is increasingly recognized pathologically. The aim of this study was to evaluate the imaging features of FH-RCC on computed tomography (CT), magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography (FDG PET), and to determine the pre-operative diagnostic potential of imaging. This single-site retrospective study included patients with histologically confirmed FH-RCC or with a renal cancer and known germline FH mutation; imaging of the renal mass before treatment with contrast-enhanced CT, contrast-enhanced MRI, or FDG PET/CT between October 2007 and May 2019. Clinical information, pathological data, and imaging features were analyzed and reported descriptively. Sixteen patients with sixteen tumors were included (median age 46 years, interquartile range 38–53 years; 31 % female). Almost all tumors were unifocal (15/16, 94 %). Most tumors had infiltrative margins (14/16, 88 %); few were circumscribed (2/16, 12 %). A large cystic tumor component (> 75 % of tumor volume) was seen in 8/16 (50 %) of tumors. Involvement of renal sinus fat was seen in 13/16 (81 %) of tumors, involvement of the hilar collecting system in 8/16 (50 %), and renal vein tumor thrombus in 6/16 (38 %). All 12 tumors (100 %) imaged with MRI had heterogenous tumor enhancement and heterogenous T2 signal. Of those patients that had diffusion-weighted imaging, 11/11 (100 %) of tumors had diffusion restriction in the solid portions of the tumor. Of the patients who had PET, 3/3 (100 %) tumors showed high metabolic activity with mean maximum standardized uptake value (SUVmax) of 16.4 (range 9.6–21.9). Patients presented with retroperitoneal nodal metastases in 69 % of cases and distant metastases in 75 %. Of those four patients without metastatic disease at presentation, three (75 %) developed metastases within 4 years of diagnosis. In our study, the majority of tumors (≥ 75 %) were unifocal, had an infiltrative margin, invaded the renal sinus fat, and presented with distant metastases. On MRI, most tumors had heterogenous T2 signal and diffusion restriction in their solid components. The small number of cases that had PET imaging showed high metabolic activity.Keywords
Funding Information
- National Cancer Institute (NIH/NCI Cancer Center Support Grant P30 CA008748)
This publication has 17 references indexed in Scilit:
- Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancerCancer, 2020
- Morphological clues to the appropriate recognition of hereditary renal neoplasmsSeminars in Diagnostic Pathology, 2018
- Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell CarcinomaThe American Journal of Surgical Pathology, 2018
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursEuropean Urology, 2016
- Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal CancerThe American Journal of Surgical Pathology, 2014
- The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) SyndromeThe American Journal of Surgical Pathology, 2007
- Increased risk of cancer in patients with fumarate hydratase germline mutationJournal of Medical Genetics, 2006
- Hereditary Renal CancersRadiology, 2003
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002
- Inherited susceptibility to uterine leiomyomas and renal cell cancerProceedings of the National Academy of Sciences of the United States of America, 2001